Ziprasidone 20mg Capsules

Ziprasidone 20mg is an atypical antipsychotic used for schizophrenia and acute manic or mixed episodes associated with bipolar disorder. It helps manage disturbed thinking, hallucinations and marked mood or behavioural activation.
Swallow the capsule with a proper meal at each scheduled dose; a light snack or an empty stomach may give inadequate absorption. Keep meal timing consistent. Changes in treatment are gradual rather than an abrupt switch or stop.
Ziprasidone modulates dopamine D2 and serotonin 5-HT2A receptor activity. These effects help reduce psychotic symptoms and stabilise symptoms of mania.
Drowsiness, dizziness, nausea, restlessness and abnormal movements can occur. Fainting, palpitations, severe rash or fever with muscle stiffness and confusion require urgent assessment.
A history of prolonged QT interval, serious arrhythmia or low potassium or magnesium is particularly important. Other QT-prolonging medicines can increase cardiac risk. ECG, electrolyte, glucose and lipid monitoring may be appropriate. Alcohol can worsen sedation.
Can reduce hallucinations, disorganised thinking and manic symptoms, helping improve functioning and stability during treatment.
Food substantially increases ziprasidone absorption. An unchanged dose taken without food can deliver less medicine than expected.
No. Sleepiness is an adverse effect; its therapeutic role is treatment of psychosis or bipolar symptoms.
Ziprasidone can lengthen the heart's QT interval, making rhythm assessment important when cardiac or interaction risks are present.
It may be akathisia, a movement-related adverse effect, rather than worsening anxiety. Report it so treatment can be assessed.
Abrupt discontinuation can destabilise symptoms. A planned change reduces relapse and withdrawal problems.
Atypical antipsychotic: a medicine used to treat psychotic and some mood symptoms. Mania: a state of abnormally elevated or irritable mood and activity. QT interval: an ECG measure of cardiac electrical recovery. Akathisia: distressing motor restlessness; AR: Ziprasidone 20mg كبسولات; FR: Ziprasidone 20mg gélules; PT: Ziprasidone 20mg cápsulas; ES: Ziprasidone 20mg cápsulas; RU: Ziprasidone 20mg капсулы; ID: Ziprasidone 20mg kapsul; VI: Ziprasidone 20mg viên nang; MS: Ziprasidone 20mg kapsul; TL: Ziprasidone 20mg kapsula; ZH-SG: Ziprasidone 20mg 胶囊
International B2B Enquiry
Send a structured B2B enquiry for Ziprasidone 20mg Capsules under Mental Health. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Ziprasidone 20mg Capsules